Drug
SD 101 Dermal
SD 101 Dermal: highest development phase Phase 2, developed by Amicus Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Amicus Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| SD-101 dermal cream (3%) NCT02014376 | Phase 2 | Epidermolysis Bullosa |
| SD-101 dermal cream (6%) NCT02090283 | Phase 2 | Epidermolysis Bullosa |
Latest
No recent events.
Follow SD 101 Dermal on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.